Global Retirement Partners’s Tarsus Pharmaceuticals TARS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$5.98K Buy
73
+19
+35% +$1.42K ﹤0.01% 3376
2025
Q3
$3.21K Buy
54
+6
+13% +$295 ﹤0.01% 3145
2025
Q2
$1.94K Buy
+48
New +$2.16K ﹤0.01% 3250
2024
Q4
Sell
-38
Closed -$1.25K 3775
2024
Q3
$1.25K Buy
+38
New +$1.07K ﹤0.01% 3089

Other funds holding TARS

Global Retirement Partners's TARS Position: Q4 2025 in Review

Global Retirement Partners increased its Tarsus Pharmaceuticals (TARS) stake by 35% in Q4 2025, buying an estimated $1.42K and bringing the position to 73 shares worth $5.98K. The position accounts for ﹤0.01% of the portfolio, ranked #3376.

Global Retirement Partners first reported a position in TARS in Q3 2024 and has held it in 4 quarters since. 246 funds tracked by Wall St. Rank hold TARS as of Q4 2025.

  • Global Retirement Partners held 73 shares of Tarsus Pharmaceuticals worth $5.98K as of Q4 2025.
  • Global Retirement Partners bought 19 Tarsus Pharmaceuticals shares in Q4 2025, an estimated $1.42K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3376 holding.
  • Global Retirement Partners first reported a position in Tarsus Pharmaceuticals in Q3 2024 and has held it in 4 quarters since.
  • 246 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.